Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Histone deacetylase inhibitors
Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/09/2021
Deguelin
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/09/2021
Sorafenib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021
Nilotinib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021
Prednisolone
Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/09/2021
Furosemide
Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/09/2021
Tipiracil 
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021
AT-511
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/08/2021
W25
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/08/2021
S-FL-opt/S1 recombinant protein
Potential treatment - pre-clinical evidence Experimental Vaccine Feb/08/2021
Salvianolic acid C
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/08/2021
12f
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/08/2021
S-8510
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
(2s,3r)-2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-2,3-dihydro-4h-chromen-4-one
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
ZINC104875569
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
FN3D
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021
FN3B
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021
FN3A
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021
FN3C
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021
Enoximone
Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/05/2021